ADORA2A and Parkinson disease: In agreement with these results, a previous study showed that the administration of istradefylline resulted in a significant reduction in immobility time in FST in the PD model in both rats and mice, suggesting an antidepressant effect of the selective A2AR antagonist istradefylline [74].